These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35774616)

  • 1. Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis.
    Lu J; Hu D; Ma C; Shuai B
    Front Pharmacol; 2022; 13():938447. PubMed ID: 35774616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progresses in the Treatment of Osteoporosis.
    Li SS; He SH; Xie PY; Li W; Zhang XX; Li TF; Li DF
    Front Pharmacol; 2021; 12():717065. PubMed ID: 34366868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review on the protective activity of osthole against the pathogenesis of osteoporosis.
    Chen J; Liao X; Gan J
    Front Pharmacol; 2023; 14():1236893. PubMed ID: 37680712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
    Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
    Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriate models for novel osteoporosis drug discovery and future perspectives.
    Gennari L; Rotatori S; Bianciardi S; Gonnelli S; Nuti R; Merlotti D
    Expert Opin Drug Discov; 2015; 10(11):1201-16. PubMed ID: 26292627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and mechanistic aspects of quercetin in osteoporosis.
    Deng TT; Ding WY; Lu XX; Zhang QH; Du JX; Wang LJ; Yang MN; Yin Y; Liu FJ
    Front Pharmacol; 2024; 15():1338951. PubMed ID: 38333006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Teriparatide and Sequential Antiresorptive Agent Treatment Among Elderly Female Medicare Beneficiaries.
    Liu J; Laster A; Xu X; Guo H; Oates M; Gandra SR
    J Bone Miner Res; 2021 Dec; 36(12):2309-2316. PubMed ID: 34490946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on osteoporosis therapies.
    Cairoli E; Zhukouskaya VV; Eller-Vainicher C; Chiodini I
    J Endocrinol Invest; 2015 Mar; 38(3):303-11. PubMed ID: 25577263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential therapy in the treatment of osteoporosis.
    Boonen S; Milisen K; Gielen E; Vanderschueren D
    Curr Med Res Opin; 2011 Jun; 27(6):1149-55. PubMed ID: 21466276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action and synergetic formulas of plant-based natural compounds from traditional Chinese medicine for managing osteoporosis: a literature review.
    Zhou C; Shen S; Zhang M; Luo H; Zhang Y; Wu C; Zeng L; Ruan H
    Front Med (Lausanne); 2023; 10():1235081. PubMed ID: 37700771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoanabolic Agents for Osteoporosis.
    Haas AV; LeBoff MS
    J Endocr Soc; 2018 Aug; 2(8):922-932. PubMed ID: 30087947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.
    Bilezikian JP
    Curr Osteoporos Rep; 2008 Mar; 6(1):24-30. PubMed ID: 18430397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifracture efficacy of currently available therapies for postmenopausal osteoporosis.
    Reginster JY
    Drugs; 2011 Jan; 71(1):65-78. PubMed ID: 21175240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Anti-Osteoporosis Polysaccharides Derived from Medicinal Herbs and Other Edible Substances.
    Zhao Z; Nian M; Lv H; Yue J; Qiao H; Yang X; Zheng X
    Am J Chin Med; 2022; 50(2):441-470. PubMed ID: 35021963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The osteoporosis needs of patients with wrist fracture.
    Bogoch ER; Elliot-Gibson V; Escott BG; Beaton DE
    J Orthop Trauma; 2008 Sep; 22(8 Suppl):S73-8. PubMed ID: 18753893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
    Hough S
    S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems pharmacology dissection of action mechanisms of Dipsaci Radix for osteoporosis.
    Zhang W; Xue K; Gao Y; Huai Y; Wang W; Miao Z; Dang K; Jiang S; Qian A
    Life Sci; 2019 Oct; 235():116820. PubMed ID: 31476308
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.